FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 293:675-680 October 2, 1975 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We conducted a double-blind study to determine the efficacy of 17alpha-hydroxyprogesterone caproate in preventing premature delivery in 43 high-risk patients. Premature delivery did not occur in 18 patients receiving the progestational agent, whereas 41 per cent of the 22 receiving the palcebo had premature delivery (P less than 0.01). The mean duration of pregnancy and the mean birth weight in the former group (38.6 weeks +/- 1.6 S.D., and 2836 g +/- 412 S.D.) were both significantly greater (P less than 0.025) than that in the latter (35.2 weeks +/- 6.7 S.D.; 2361 g +/- 1085 S.D.). The perinatal mortality rate in the group given the progestational agent (O per cent) was significantly less than that observed in the placebo group (27 per cent) (P less than 0.05). Although there were no complications attributable to the progestational drug, the study population was too small for assessment of immediate or long term safety. However, the results indicate a possible obstetric use for this drug.

This article has been cited by other articles:

• Yellon, S. M., Ebner, C. A., Elovitz, M. A. (2009). Medroxyprogesterone Acetate Modulates Remodeling, Immune Cell Census, and Nerve Fibers in the Cervix of a Mouse Model for Inflammation-induced Preterm Birth. Reproductive Sciences 16: 257-264 [Abstract]  
• O'Brien, J. M., Chandiramani, M., Tribe, R., Shennan, A., Nicolaides, K. H., Celik, E., Fonseca, E. B., Rouse, D. J., Thom, E. A., Spong, C. Y., the NICHD Maternal Fetal Medicine Units Network, (2007). Progesterone and Preterm Birth. NEJM 357: 2306-2307 [Full Text]  
• Meis, P. J., Klebanoff, M., Thom, E., Dombrowski, M. P., Sibai, B., Moawad, A. H., Spong, C. Y., Hauth, J. C., Miodovnik, M., Varner, M. W., Leveno, K. J., Caritis, S. N., Iams, J. D., Wapner, R. J., Conway, D., O'Sullivan, M. J., Carpenter, M., Mercer, B., Ramin, S. M., Thorp, J. M., Peaceman, A. M., the National Institute of Child Health and Human D, (2003). Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate. NEJM 348: 2379-2385 [Abstract] [Full Text]  
• Greene, M. F. (2003). Progesterone and Preterm Delivery -- Deja Vu All Over Again. NEJM 348: 2453-2455 [Full Text]  
• Goldenberg, R. L., Rouse, D. J. (1998). Prevention of Premature Birth. NEJM 339: 313-320 [Full Text]